$CVNA $CTAS $KBH $MKC $TSLA
-27.76%
$AEP $BG -16.91%
$CSIQ $EPAC $EOG $OKLO $PSN $FTI $AURA -3.95%
$XAIR $MRK $NGNE $BABA +8.89%
$NET -9.55%
$CCI $cVOWGY QUICK MARKET SUMMARY:
Consumer
๐ธ Carvana ( $CVNA) upgraded to Overweight at Morgan Stanley; PT raised to $280 from $260.
๐ธ Cintas ( $CTAS) ended talks to buy UniFirst (UNF) for $275/share.
๐ธ KB Home ( $KBH) Q1 miss: revenue down 5%, net income down 21%, lowers FY25 outlook; appoints Robert Dillard as CFO.
๐ธ McCormick ( $MKC) Q1 EPS $0.60 (vs. $0.64 est.), reaffirms FY25 guidance.
๐ธ Smithfield Foods sees higher annual sales and profit.
๐ธ Tesla ( $TSLA) European market share down sharply; YTD sales -42.6%.
Energy, Industrials & Materials
๐ธ American Electric ( $AEP) announces $2B stock offering.
๐ธ Bunge ( $BG) selling European margarine business to Vandemoortele.
๐ธ Canadian Solar ( $CSIQ) Q4 EPS loss (-$1.47) vs. (-$0.24) est.; record storage shipments.
๐ธ Enerpac ( $EPAC) Q2 EPS $0.38 (vs. $0.40 est.), maintains guidance.
๐ธ EOG Resources ( $EOG) downgraded to Neutral at Mizuho; PT cut to $140.
๐ธ Oklo ( $OKLO) FY24 EPS loss (-$0.74); first Aurora deployment expected late 2027.
๐ธ Parsons ( $PSN) approves $250M share buyback.
๐ธ TechnipFMC ( $FTI) wins $500Mโ$1B EPC contract from Equinor.
Healthcare
๐ธ Aura Biosciences ( $AURA) FY loss ($96M); cash runway into 2H26.
๐ธ Beyond Air ( $XAIR) secures $2M for autism therapy development.
๐ธ Merck ( $MRK) signs $200M licensing deal for Lp(a) inhibitor, potential $1.77B in milestones.
๐ธ Neurogene ( $NGNE) FY loss ($82.6M); files $300M shelf offering; cash runway into 2H27.
Tech, Media & Telecom
๐ธ Alibaba ( $BABA) to restart hiring; Chairman Tsai warns of potential AI bubble.
๐ธ Cloudflare ( $NET) double-upgraded to Buy at BofA; PT raised to $160.
๐ธ India plans to scrap 6% digital ad tax, easing pressure on U.S. tech firms.
๐ธ Crown Castle ( $CCI) appoints interim CEO Daniel Schlanger; reaffirms guidance.
๐ธ Volkswagen ( $cVOWGY) partners with Valeo and Mobileye for advanced driver-assistance systems.
From X
Disclaimer: The above content reflects only the author's opinion and does not represent any stance of CoinNX, nor does it constitute any investment advice related to CoinNX.

